GIUNTA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 11.065
AS - Asia 1.403
EU - Europa 1.386
SA - Sud America 212
AF - Africa 74
OC - Oceania 34
Totale 14.174
Nazione #
US - Stati Uniti d'America 10.999
SG - Singapore 484
CN - Cina 290
IT - Italia 209
BR - Brasile 179
DE - Germania 165
HK - Hong Kong 146
GB - Regno Unito 132
SE - Svezia 131
UA - Ucraina 123
IE - Irlanda 118
FR - Francia 112
IN - India 89
RU - Federazione Russa 75
VN - Vietnam 66
CA - Canada 48
KR - Corea 43
FI - Finlandia 42
NL - Olanda 42
TR - Turchia 42
PL - Polonia 40
PK - Pakistan 39
ID - Indonesia 35
ES - Italia 34
AU - Australia 33
BE - Belgio 33
JP - Giappone 31
EG - Egitto 29
CH - Svizzera 26
TW - Taiwan 26
HU - Ungheria 18
IQ - Iraq 17
IR - Iran 14
PH - Filippine 14
ZA - Sudafrica 14
AR - Argentina 13
MX - Messico 13
RO - Romania 13
IL - Israele 11
BD - Bangladesh 10
GR - Grecia 10
NG - Nigeria 10
AT - Austria 9
EE - Estonia 9
LT - Lituania 9
PT - Portogallo 9
EC - Ecuador 8
UZ - Uzbekistan 8
MA - Marocco 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
PE - Perù 6
DK - Danimarca 5
MY - Malesia 5
TH - Thailandia 5
BJ - Benin 4
ET - Etiopia 4
HR - Croazia 4
JO - Giordania 4
KG - Kirghizistan 4
NO - Norvegia 4
CO - Colombia 3
KW - Kuwait 3
SA - Arabia Saudita 3
LB - Libano 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GP - Guadalupe 1
JM - Giamaica 1
KE - Kenya 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
NA - Namibia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UG - Uganda 1
Totale 14.174
Città #
Wilmington 3.078
Houston 2.792
Woodbridge 2.331
Fairfield 408
Ashburn 304
Singapore 267
Chandler 236
Cambridge 168
Ann Arbor 167
Seattle 158
Hong Kong 120
Beijing 107
Dearborn 103
Rome 95
Dublin 94
Medford 86
Jacksonville 85
New York 69
Santa Clara 62
Los Angeles 45
The Dalles 45
Lawrence 39
Munich 31
Dallas 30
Zhengzhou 30
Jönköping 28
Redwood City 28
San Diego 25
Stockholm 25
Shanghai 23
Moscow 22
Warsaw 20
Jakarta 19
London 18
Tokyo 17
Buffalo 16
Council Bluffs 15
Frankfurt am Main 15
Hanoi 14
Ho Chi Minh City 14
Montreal 14
São Paulo 14
Denver 13
Duncan 13
Hefei 13
Menlo Park 13
Milan 13
Brussels 12
Norwalk 12
Redondo Beach 12
Lahore 11
Boardman 10
Budapest 10
Central 10
Hangzhou 10
Hyderabad 10
Nanjing 10
Salcedo 10
Seoul 10
Taipei 10
Atlanta 9
Cairo 9
Delhi 9
Ottawa 9
Toronto 9
Chicago 8
Johannesburg 8
Kraków 8
Kunming 8
Lagos 8
Lappeenranta 8
New Delhi 8
Palo Alto 8
San Francisco 8
Sydney 8
Ankara 7
Baghdad 7
Bengaluru 7
Bucharest 7
Dong Ket 7
Esslingen am Neckar 7
Naples 7
Nuremberg 7
Phoenix 7
Tallinn 7
Utrecht 7
Amsterdam 6
Düsseldorf 6
Guayaquil 6
Huskvarna 6
Islamabad 6
Istanbul 6
Konya 6
Lima 6
Madrid 6
Bankeryd 5
Belo Horizonte 5
Biên Hòa 5
Brasília 5
Chennai 5
Totale 11.760
Nome #
European S3-guidelines on the systemic treatment of psoriasis vulgaris 1.558
Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis 680
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 456
New topical treatments for psoriasis 447
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 441
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 435
Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience 424
Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management 422
Resolution of idiopathic recurrent pericarditis in a psoriatic arthritis patient treated with etanercept 413
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis 412
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 398
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 394
Morbid obesity and psoriasis: Disease remission after laparoscopic sleeve gastrectomy 394
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse 390
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 377
Association between psoriasis and periodontitis, and efficacy of anti-TNF-α therapy: a case series 366
From patients’ needs to treatment outcomes in psoriasis: Results from the ‘pSORRIDI’ experience 359
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 357
Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy 353
Long-lasting remission of pemphigus vulgaris treated with rituximab 346
Histopathology of the skin in rheumatic diseases 346
Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumab 346
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 333
Early detection of IgH monoclonal rearrangenent in follicular spicules of the nose preceding multiple myeloma diagnosis. Case report and review of the literature 322
Treatment of Hailey-Hailey disease with topical calcitriol 321
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry 314
Etanercept biosimilar SB4 in the treatment of plaque-type psoriasis and psoriatic arthritis: a single-center, observational, retrospective, real-life study 300
A case of generalized pustular psoriasis and arthritis treated with ixekizumab 289
null 287
Long-term treatment with etanercept monotherapy in a hemodialyzed patient with moderate-to-severe plaque-type psoriasis and psoriatic arthritis 264
Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infections 256
Therapeutic monitoring of male genital lichen sclerosus: usefulness of reflectance confocal microscopy 235
The economic impact of biosimilars in Italy: a scenario analysis 232
Long-term safety and efficacy of secukinumab in patients with psoriasis and major psychiatric disorders: a case series 172
The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab 157
Depressive symptoms and insecure attachment predict disability and quality of life in psoriasis independently from disease severity 142
Efficacy and safety of ixekizumab in psoriatic arthritis: a retrospective, single-centre, observational study in a real-life clinical setting 103
Ixekizumab in nail psoriasis 103
Connective tissue nevus in Marfan syndrome successfully treated with intralesional steroid injections 91
High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosis 72
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 68
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 63
Combination therapy with etanercept in psoriasis: Retrospective analysis of efficacy and safety outcomes from real-life practice 60
Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution 54
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis) 52
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis) 37
Effectiveness of ixekizumab in elderly patients for the treatment of moderate-to-severe psoriasis: results from a multicenter, retrospective real-life study in the Lazio region 34
Totale 14.475
Categoria #
all - tutte 33.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.111 0 0 0 0 0 271 282 242 87 100 84 45
2021/2022688 28 88 50 66 22 52 49 44 55 47 60 127
2022/2023768 64 75 37 93 61 112 66 63 91 23 39 44
2023/2024488 48 26 28 31 39 99 49 52 12 22 23 59
2024/20251.126 46 233 115 88 31 69 82 58 91 101 124 88
2025/2026950 181 90 264 201 167 47 0 0 0 0 0 0
Totale 14.475